Recombinant Insulin anticorps
Aperçu rapide pour Recombinant Insulin anticorps (ABIN7127574)
Antigène
Voir toutes Insulin (INS) AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Réactivité croisée
- Humain
-
Purification
- Affinity-chromatography
-
Immunogène
- A synthesized peptide derived from human Insulin
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: IHC:1:50-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Insulin (INS)
-
Autre désignation
- INS
-
Sujet
-
Background: Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver.
Aliases: Insulin [Cleaved into: Insulin B chain, Insulin A chain], INS
-
UniProt
- P01308
-
Pathways
- Signalisation NF-kappaB, Signalisation RTK, Positive Regulation of Peptide Hormone Secretion, Peptide Hormone Metabolism, Hormone Activity, Carbohydrate Homeostasis, ER-Nucleus Signaling, Regulation of Carbohydrate Metabolic Process, Feeding Behaviour, Autophagy, Negative Regulation of intrinsic apoptotic Signaling, Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation
Antigène
-